282 related articles for article (PubMed ID: 16735487)
1. Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial.
Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
J Clin Endocrinol Metab; 2006 Aug; 91(8):2946-51. PubMed ID: 16735487
[TBL] [Abstract][Full Text] [Related]
2. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
Bonnema SJ; Grupe P; Boel-Jørgensen H; Brix TH; Hegedüs L
Eur J Clin Invest; 2011 Jul; 41(7):693-702. PubMed ID: 21175612
[TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.
Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
J Clin Endocrinol Metab; 2004 Sep; 89(9):4439-44. PubMed ID: 15356044
[TBL] [Abstract][Full Text] [Related]
5. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
6. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial.
Bonnema SJ; Bennedbaek FN; Gram J; Veje A; Marving J; Hegedus L
Eur J Endocrinol; 2003 Dec; 149(6):485-92. PubMed ID: 14640988
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
Kabadi U; Cech R
Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine.
Azizi F; Ataie L; Hedayati M; Mehrabi Y; Sheikholeslami F
Eur J Endocrinol; 2005 May; 152(5):695-701. PubMed ID: 15879354
[TBL] [Abstract][Full Text] [Related]
12. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
13. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
14. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
16. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
17. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
Braga M; Walpert N; Burch HB; Solomon BL; Cooper DS
Thyroid; 2002 Feb; 12(2):135-9. PubMed ID: 11916282
[TBL] [Abstract][Full Text] [Related]
18. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
19. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]